Model Information:
Pleomorphic xanthoastrocytoma of the frontotemporal region, WHO grade II.
Request a Custom Quote for XB5010 Xenograft ModelSummary:
| Category | Parameter | Model Detail (XB5010) |
| Identity | Model ID | XB5010 |
| Cancer Type | Brain Cancer | |
| Model Type | PDX (Patient-Derived Xenograft) | |
| Clinical Background | Patient Age | 26 |
| Patient Gender | Female | |
| Ethnicity | N/A | |
| Diagnosis | Pleomorphic Xanthoastrocytoma (PXA) | |
| Stage | WHO Grade 2 (Grade II) | |
| Sample Site | Frontotemporal Brain Mass | |
| Genomics & Biomarkers | Primary Driver | BRAF V600E Mutation / CDKN2A/B Deletion |
| Cytogenetics | N/A | |
| WES (Whole Exome) | N/A | |
| RNA-Seq | N/A | |
| CNV Profile | N/A | |
| Mutational Load | N/A | |
| Characterization | Surface Markers | GFAP+, S100+, CD34 (Focal), Reticulin meshwork (Positive), Ki-67 (Low-to-Moderate) |
| Host Strain | NSG (NOD scid gamma) | |
| Inoculation Route | Orthotopic / Subcutaneous | |
| Growth Kinetic | N/A | |
| Pharmacology | SoC Response | N/A |
| Immune Profiling | N/A |
Growth Characteristics:
